Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.71 |
| ▸ | TSHR | P16473 | 1/20 | 0.71 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.61 |
| ▸ | PGR | P06401 | 1/20 | 0.61 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.61 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | FAAH | O00519 | 2/20 | 0.58 |
| ▸ | DGKA | P23743 | 1/20 | 0.57 |
| ▸ | F7 | P08709 | 2/20 | 0.56 |
| ▸ | F3 | P13726 | 2/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.56 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17024457 | 0.96 | MAPT (0.66) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL18095569 | 0.96 | MAPT (0.66) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL1172881 | 0.91 | MAPT (0.74) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL1413230 | 0.91 | ALDH1A1 (0.75) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL8702565 | 0.90 | MAPT (0.71) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL19123778 | 0.90 | ALDH1A1 (0.73) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL8702364 | 0.90 | MAPT (0.71) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL3195987 | 0.90 | ALDH1A1 (0.73) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL27796185 | 0.89 | ALDH1A1 (0.71) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL27897188 | 0.87 | ALDH1A1 (0.69) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023164280-A1 | COMPOSITIONS AND METHODS FOR CURLY HAIR | RUGHANI RONAK (US) | 2023-08-31 | — | — | WO | claimed |
| EP-3741836-B1 | ANTI-MITE UNIT DOSE ARTICLE | PROCTER & GAMBLE (US) | 2024-03-06 | — | — | EP | disclosed |
| WO-2023164280-A1 | COMPOSITIONS AND METHODS FOR CURLY HAIR | RUGHANI RONAK (US) | 2023-08-31 | — | — | WO | disclosed |
| US-20230265268-A1 | THERMOPLASTIC ELASTOMER COMPOSITION | POLYMAX THERMOPLASTIC ELASTOMERS, LLC | 2023-08-24 | — | — | US | disclosed |
| US-20230263716-A1 | Compositions and methods for treating keratin materials | L'OREAL (FR) | 2023-08-24 | — | — | US | disclosed |
| CN-111979068-B | Anti-mite unit dose article | 宝洁公司 | 2022-05-31 | — | — | CN | disclosed |
| EP-3741836-A1 | ANTI-MITE UNIT DOSE ARTICLE | The Procter & Gamble Company (US) | 2020-11-25 | — | — | EP | disclosed |
| CN-111979068-A | Anti-mite unit dose article | 宝洁公司 | 2020-11-24 | — | — | CN | disclosed |
| EP-2904046-B1 | THERMOPLASTIC ELASTOMER COMPOSITIONS HAVING BIORENEWABLE CONTENT | TEKNOR APEX CO (US) | 2018-11-21 | — | — | EP | disclosed |
| US-10125255-B2 | Thermoplastic elastomer compositions having biorenewable content | TEKNOR APEX COMPANY (US) | 2018-11-13 | — | — | US | disclosed |
| US-20020055562-A1 | Gel compositions | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2002-05-09 | — | — | US | disclosed |
| EP-1203141-A1 | LINKAGE OF AGENTS TO TISSUE | Pericor Science, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| EP-1202706-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | Pericor Science, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| WO-2002007707-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | PERICOR SCIENCE, INC. (US) | 2002-01-31 | — | — | WO | disclosed |
| EP-1171094-A1 | WET WIPES HAVING SKIN HEALTH BENEFITS | Kimberly-Clark Worldwide, Inc. (US) | 2002-01-16 | — | — | EP | disclosed |
| EP-1141111-A1 | GEL COMPOSITIONS | Penreco (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2001007009-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| WO-2001006829-A2 | LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| WO-2000064408-A1 | WET WIPES HAVING SKIN HEALTH BENEFITS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2000-11-02 | — | — | WO | disclosed |
| WO-2000026285-A1 | GEL COMPOSITIONS | PENRECO (US) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230263716-A1 | Compositions and methods for treating keratin materials | KRT18, KRTCAP2, DSG1 | ALDH1A1 3557/4885CYP3A4 4854/4885ALOX15 3652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.